Notice Number: NOT-CA-18-030
Key Dates
Release Date: December 22, 2017
PAR-18-022
Issued by
National Cancer Institute (NCI)
Purpose
This Notice corrects the Key Dates Section of Funding Opportunity (FOA) PAR-18-022 "Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)".
The following Key Dates of the FOA have been corrected (in italics):
Part 1. Key Dates
Open Date (Earliest Submission Date):
Currently reads:
March 5, 2018
Should correctly read:
March 4, 2018
Application Due Date(s):
Currently reads:
April 4, 2019; November 1, 2019; April 4, 2020; November 1, 2020; April 4, 2021, November 1, 2021, by 5:00 PM local time of applicant organization.
Should correctly read:
April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization.
AIDS Application Due Date(s):
Currently reads:
May 7, 2019; January 7, 2020; May 7, 2020; January 7, 2021; May 7, 2021, January 7, 2022.
Should correctly read:
May 7, 2018; January 7, 2019; May 7, 2019, January 7, 2020.
Scientific Merit Review:
Currently reads:
June 2019; February 2020; June 2020; February 2021; June 2021; February 2022
Should correctly read:
June 2018; February 2019; June 2019; February 2020
Advisory Council Review:
Currently reads:
October 2019; May 2020; October 2020; May 2021; October 2021; May 2022
Should correctly read:
October 2018; May 2019; October 2019; May 2020
Earliest Start Date:
Currently reads:
October 2019; May 2020; October 2020; May 2021; October 2021; May 2022
Should correctly read:
October 2018; May 2019; October 2019; May 2020
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Mark Parascandola, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6871
Email: Mark.Parascandola@nih.gov
and Human Services (HHS)
